Novel Agent Reduces Bowel Movement Frequency in Carcinoid Syndrome

Life-threatening diarrhea in neuroendocrine tumors: two case reports, Journal of Medical Case Reports

Carcinoid Tumour

Efficacy, safety and unmet needs of evolving medical treatments for carcinoid syndrome - Koumarianou - 2022 - Journal of Neuroendocrinology - Wiley Online Library

PDF) What Gastroenterologists Should Know about Carcinoid Syndrome

Gastrointestinal Neuroendocrine Tumors and the Carcinoid Syndrome - Endotext - NCBI Bookshelf

Full article: Real-world treatment patterns, resource use and costs of treating uncontrolled carcinoid syndrome and carcinoid heart disease: a retrospective Swedish study

Mean change from baseline in stool form at six weeks for patients

Irritable bowel syndrome - Wikipedia

Clinical Trial of Paltusotine, an oral somatostatin analogue for

Proportion of patients with improved CS symptoms (lower post-baseline

PDF) Novel Therapy of the Carcinoid Syndrome Related Diarrhea

Frontiers Biomarkers for Pancreatic Neuroendocrine Neoplasms (PanNENs) Management—An Updated Review

Gastroenterology Insights, Free Full-Text

Frontiers Action Mode of Gut Motility, Fluid and Electrolyte

The role of serotonin inhibition within the treatment of carcinoid syndrome in: Endocrine Oncology Volume 3 Issue 1 (2023)